FDA halts use of antibody drugs that don't work vs. omicron

[KARE11 News, January 25, 2022] The FDA has withdrawn emergency use authorization for two monoclonal antibodies because they are not effective against the now prevalent omicron COVID variant. Allina Health infectious disease specialist Frank Rhame, MD, talked to KARE 11 News about why that is and what treatments remain to fight COVID infections.

Posted on January 26, 2022 in coronavirus

Share this article